Literature DB >> 3736599

Preventive screening for the fragile X syndrome.

G Turner, H Robinson, S Laing, S Purvis-Smith.   

Abstract

In an Australian population of 1.2 million, we screened 1977 intellectually handicapped persons, who were identified through the public schools and sheltered workshops, for the X-linked semidominant fragile X syndrome. We excluded 527 because they had another known diagnosis. The remaining 1450 were offered chromosomal analysis. Of the 1117 who consented (77 percent), an additional 196 were excluded, and among the 921 who were tested cytogenetically, 40 probands were found. Prevalence rates for persons with an intellectual handicap and the fragile X syndrome in the public school population were 1:2610 for males and 1:4221 for females. Family studies identified 84 women who were either obligate carriers or at high risk of being carriers, who were under the age of 35 and had no children. These women were given genetic counseling, and the availability of antenatal diagnosis was explained to them. If each of these 84 women had two children, 27 of their sons would have an intellectual handicap. We recommend cytogenetic screening for the fragile X syndrome in all currently identified intellectually handicapped people, followed by routine screening of children newly identified as intellectually handicapped in the school system.

Entities:  

Mesh:

Year:  1986        PMID: 3736599     DOI: 10.1056/NEJM198609043151002

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  30 in total

1.  Fragile X syndrome among children with mental retardation.

Authors:  R Elango; I C Verma
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

Review 2.  Fragile X mental retardation.

Authors:  R M Winter
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

3.  Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group.

Authors:  B B de Vries; A M van den Ouweland; S Mohkamsing; H J Duivenvoorden; E Mol; K Gelsema; M van Rijn; D J Halley; L A Sandkuijl; B A Oostra; A Tibben; M F Niermeijer
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

4.  Clinico-neurological investigations in the fra(X) form of mental retardation.

Authors:  P Vieregge; U Froster-Iskenius
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

5.  A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases.

Authors:  F Rousseau; D Heitz; J Tarleton; J MacPherson; H Malmgren; N Dahl; A Barnicoat; C Mathew; E Mornet; I Tejada
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

6.  Prevalence of the fragile X syndrome in four birth cohorts of children of school age.

Authors:  M Kähkönen; T Alitalo; E Airaksinen; R Matilainen; K Launiala; S Autio; J Leisti
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

7.  Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.

Authors:  H Toledano-Alhadef; L Basel-Vanagaite; N Magal; B Davidov; S Ehrlich; V Drasinover; E Taub; G J Halpern; N Ginott; M Shohat
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

8.  Frequency of the fragile X syndrome in institutionalized mentally retarded females in Japan.

Authors:  T Arinami; I Kondo; S Nakajima; H Hamaguchi
Journal:  Hum Genet       Date:  1987-08       Impact factor: 4.132

9.  Auditory brain-stem responses in the fragile X syndrome.

Authors:  T Arinami; M Sato; S Nakajima; I Kondo
Journal:  Am J Hum Genet       Date:  1988-07       Impact factor: 11.025

10.  Population studies of the fragile X: a molecular approach.

Authors:  P A Jacobs; H Bullman; J Macpherson; S Youings; V Rooney; A Watson; N R Dennis
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.